Moderlax (Bisacodyl)

Bisacodyl works by directly stimulating the nerve endings in the colon, increasing peristaltic contractions. It also promotes the secretion of water and electrolytes into the intestinal lumen, which softens stool and facilitates its passage through the gastrointestinal tract.

The appropriate dose of Moderlax is determined by a qualified prescriber based on the patient’s condition, age, and response to therapy. Typical adult regimens may involve a single dose for bowel preparation or a short‑term course for constipation, but exact dosing must follow the healthcare professional’s instructions.

The safety of bisacodyl in pregnancy and lactation has not been definitively established. Healthcare providers usually weigh the potential benefits against possible risks before prescribing it to pregnant or nursing women. Consultation with a physician is essential before use in these populations.

To order Moderlax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with bulk‑forming agents, bisacodyl provides a faster onset of action by actively stimulating colonic motility. Unlike osmotic laxatives, it does not rely on drawing water into the bowel, which can be advantageous in patients needing rapid evacuation. However, stimulant laxatives may cause cramping and should be used for short periods.

Moderlax should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Moderlax is taken orally, usually with a full glass of water. For constipation, it may be taken at bedtime to produce a bowel movement the following morning. For bowel preparation, the timing and dosage are directed by the prescribing clinician to ensure adequate colon cleansing before the procedure.

Serious risks, though uncommon, include severe dehydration, electrolyte imbalance, allergic reactions such as rash or anaphylaxis, and, in rare cases, colonic perforation. Patients should seek immediate medical attention if they experience signs of severe dehydration, persistent abdominal pain, or any allergic symptoms.

Moderlax should be avoided in individuals with known intestinal obstruction, acute abdominal pain of unknown cause, severe inflammatory bowel disease, or hypersensitivity to bisacodyl or any excipients. It is also contraindicated in patients who have recently undergone bowel surgery without medical guidance.